Clinical trial Recruiting at 3 sites Phase2; Phase3 Interventional Ages 25 to 80

Aphasia rehabilitation with tDCS as added to speech therapy

Official title: Transcranial Direct Current Stimulation to Treat Aphasia: A Superiority Study

Run by University of South Carolina · NCT07688551 · Data updated 2026-11-12

We are testing whether adding non-invasive brain stimulation (tDCS) to speech therapy helps people with Broca's aphasia after stroke more than speech therapy alone.

More Aphasia trials

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages25 Years to 80 Years
SexAll
Enrollment130 (estimated)
SponsorUniversity of South Carolina
Academic / other
Locations3 sites (Charleston, South Carolina and 2 other locations)
StatusRecruiting
StartedJuly 14, 2026
Main results expectedMarch 2030
Study endsJune 2030
Registry record updatedJuly 21, 2026
Trial IDNCT07688551 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 25–80 with chronic left-hemisphere stroke causing Broca's aphasia, fluent in English for at least 15 years, and meeting specific language impairment criteria.

Probably not a fit

People without Broca's aphasia or those with recent stroke, different aphasia types, or who do not meet the language/diagnostic criteria may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind trial compares auditory-visual speech therapy with active anodal tDCS to speech therapy with sham tDCS in adults with chronic Broca's aphasia. An adaptive Phase II/III design will identify the optimal tDCS dose (1 mA vs 2 mA) in Phase II and then test the confirmed dose in Phase III. Stimulation uses the 10-10 electrode system with 5 x 5 cm pads for 20 minutes per session, alongside speech therapy aiming to improve naming abilities. Participants must have had a left-hemisphere stroke and Broca's aphasia for more than six months, among other criteria, and will be randomized to active or sham tDCS. The study is conducted at multiple sites in the southeastern and western United States.

Why it matters

Potential benefit: If successful, this approach could enhance naming and language recovery for people with chronic Broca's aphasia when combined with speech therapy.

How similar studies have gone: Prior studies in neuromodulation and aphasia have shown potential benefits with tDCS, but results vary across designs and cohorts; this trial uses an adaptive Phase II/III approach to establish efficacy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be willing and able to give informed consent.
* Be willing and able to comply with study requirements.
* Be between 25 and 80 years of age.
* Have used English as the primary language for \> 15 years.
* Have the diagnosis of aphasia due to a left hemisphere stroke, confirmed by study physician based on past clinical MRI scan or research scan.
* Be greater than 6 months post-stroke.
* Have Broca's aphasia diagnosed by the WAB-R (fluency score ≤ 5, auditory verbal comprehension score 4-10, repetition score 0-7.9, naming and word finding score \< 9).
* Correctly name 140 or fewer items on the PNT.

Exclusion Criteria:

* History of brain surgery except for during the treatment of the acute stroke.
* Seizures during the previous 12-months.
* Compromised skin at or near electrode sites (e.g., rash, eczema, wounds, infection).
* Correctly name more than 140 out of 175 items during the pre-treatment picture naming test (Philadelphia Naming Test).
* Western Aphasia Battery-Revised Aphasia Quotient (WAB-R AQ) score of 25 or below.
* Participants with open skull defects (e.g., greater than 1 cm) in the area underneath the anode electrode positioning or participants with metal implants or electrical stimulators.
* Participants with continuous oxygen therapy which cannot be discontinued for more than 1 hour.
* Any condition or situation that the PI determines would significantly interfere with the participant's ability to complete the study.

Where it's running

  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting
  • University of South Carolina
    Columbia, South Carolina, United States
    Recruiting
  • University of Utah
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.